BioStem Technologies, Inc.
BSEM
$3.71
$0.102.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -211.35% | -160.95% | -121.21% | 42.02% | 388.76% |
| Total Depreciation and Amortization | 423.20% | 203.15% | 41.58% | 34.70% | 17.55% |
| Total Amortization of Deferred Charges | -100.00% | -90.06% | -74.49% | -73.03% | -64.11% |
| Total Other Non-Cash Items | 411.04% | 571.87% | 372.33% | -41.37% | -49.73% |
| Change in Net Operating Assets | 121.94% | 152.72% | 64.89% | -30.53% | 68.20% |
| Cash from Operations | -121.88% | -81.99% | -59.37% | 2.38% | 430.67% |
| Capital Expenditure | -289.29% | -450.80% | -685.63% | -931.49% | -175.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.00% | 200.00% | 200.00% | 209.17% | -1,290.48% |
| Cash from Investing | -734.83% | -827.17% | -25.34% | -16.22% | -634.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.14% | -93.94% | -39.84% | -4.83% | 12.12% |
| Issuance of Common Stock | 490.51% | -96.48% | -92.48% | -85.08% | -81.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -62.15% | -739.65% | -475.65% | -180.52% | -155.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.39% | -149.83% | -70.27% | -13.51% | 288.45% |